Prognostic factors in stage T3N0 rectal cancer: Do all patients require postoperative pelvic irradiation and chemotherapy?

Diseases of the Colon and Rectum

Volumn 42, Issue 2, 1999, Pages 167-173

  Willett, Christopher G ^a   Badizadegan, Kamran ^b   Ancukiewicz, Marek ^a   Shellito, Paul C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adjuvant radiation therapy and chemotherapy; Prognostic markers; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PROGNOSIS; RECTUM CANCER; TREATMENT INDICATION; TREATMENT PLANNING;

CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM STAGING; PELVIS; POSTOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0033007459     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02237122     Document Type: Article

References (16)

1. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following curative surgery for adenocarcinoma of the rectum: Clinico-pathologic correlation and implications for adjuvant therapy. Cancer 1974;34:1278-92.
2. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983;52: 1317-29.
3. Vigliotti A, Rich TA, Romsdahl M, Withers HR, Oswald MJ. Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid. Int J Radiat Oncol Biol Phys 1987;13:999-1006.
4. Schild SE, Martenson JA, Gunderson LL, et al. Postoperative adjuvant therapy of rectal cancer: an analysis of disease control, survival and prognostic factors. Int J Radiat Oncol Biol Phys 1989;17:55-62.
5. Willett CG, Tepper JE, Kaufman DS, et al.: Adjuvant postoperative radiation therapy for rectal adenocarcinoma. Am J Clin Oncol 1992;15:371-5.
6. Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-72.
7. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal cancer. N Engl J Med 1991;324:709-15.
8. Gastrointestinal Tumor Study Group. Radiation therapy and 5-FU with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992;10:549-57.
9. O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1995;331:502-7.
10. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997; 15:2030-9.
11. NIH Consensus Conference. Adjuvant therapy for patients with colorectal cancer. JAMA 1990;264:1444-50.
12. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Ilstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg 1994;220:676-82.
13. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 1986;2:996-9.
14. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
15. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. The Lancet 1993;341:457-60.
16. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995;181:335-46.